Results 251 to 260 of about 118,295 (302)
Serum Cytokine Profiling Differentiates Underlying Diseases in Cytokine Storm Syndrome
Serum cytokine profiling was performed using Luminex (48 cytokines) and ELISA (5 cytokines). Assessment of key cytokines (IFN‐α, IL‐18, IL‐6, CXCL9) delineated five dominant inflammatory patterns: I, IFN‐α–dominant CSS; II, IL‐18–dominant CSS; III, IL‐6–dominant CSS; IV, IFN‐γ–dominant CSS; and V, IL‐6 & IFN‐γ intermediate CSS.
Shuya Kaneko +42 more
wiley +1 more source
Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy [PDF]
Alma M. G. +10 more
core
Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm +2 more
wiley +1 more source
Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?
Objective Lupus nephritis (LN) is characterized by a variable disease course, necessitating continuous monitoring. There is an urgent need to identify noninvasive biomarkers. By reviewing and critically assessing the quality of existing studies on LN biomarkers correlating with histopathology, we here explore the challenges in promoting their use in ...
Valentina Querin +11 more
wiley +1 more source
Clinical Images: Sarcoidosis revealed by recurrent dactylitis
Arthritis &Rheumatology, EarlyView.
Thomas Subervie +7 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Interferon-Gamma Release Assays
Clinics in Laboratory Medicine, 2014Diagnosis of latent tuberculosis infection (LTBI) should be targeted toward individuals and groups with high risk of progression to active tuberculosis (TB). Low-risk populations should not be screened. Interferon-gamma release assays (IGRAs) perform as well or better than the tuberculin skin test in most targeted populations.
Robert, Belknap, Charles L, Daley
openaire +2 more sources
Interferon gamma release assays: principles and practice
Enfermedades Infecciosas y Microbiología Clínica, 2010The last decade has witnessed significant advances in mycobacterial genomics and cellular research which have resulted in the development of two new blood tests, the enzyme-linked immunospot assay (ELISpot) (TSPOT.TB, Oxford Immunotec, Oxford, UK) and the enzyme-linked immunosorbent assay (ELISA) (QuantiFERON-TB Gold In-Tube, Cellestis, Carnegie ...
Ajit, Lalvani, Manish, Pareek
openaire +2 more sources
Tuberculin skin test versus interferon-gamma release assays
Acta Clinica Belgica, 2014Dear Editor,We would like to discuss on the publication on ‘Tuberculin skin test versus interferon-gamma release assays.’1 De Keyser et al.
S S, Tin, V, Wiwanitkit
openaire +2 more sources
Role of interferon-gamma release assays in healthcare workers
Journal of Hospital Infection, 2009The advent of interferon-gamma release assays (IGRAs) provides new options for detection of latent tuberculosis infection (LTBI). This is particularly relevant to healthcare workers (HCWs), who are at higher risk of infection, but who have often also been vaccinated.
J E, Swindells +3 more
openaire +2 more sources

